Name | KI (μM) | Km (μM) | Vmax | Vmax/Km |
Norepinephrine | 63.9 ± 2.3 | 0.28 ± 0.03 | 5.83 ± 0.49 | 21.3 ± 2.4 |
HED | 43.2 ± 1.8 | 0.48 ± 0.08 | 5.43 ± 0.71 | 11.4 ± 1.3 |
4-18F-MHPG | 5.6 ± 0.5 | 2.57 ± 0.35 | 7.46 ± 0.64 | 3.0 ± 0.5 |
HED | — | — | — | 2.66 ± 0.39 |
MIBG | 0.052 | 0.23 | 4.4 | 3.6 ± 0.2 |
KI = binding affinity; Km = Michaelis constant; Vmax = maximum velocity.
Data are for cloned human norepinephrine transporter stably expressed in rat C6-glial cells. Using tritium-labeled compounds, 7 different unlabeled substrate concentrations were added; 3 compounds are reported here. Cellular uptake was analyzed by Michaelis–Menten equations. C6-human NET membrane was used for binding assays. For competitive binding assays, percentage of specific binding vs. inhibitor concentration data was fitted to one-site competition model. KI values were calculated from estimated inhibition concentration of 50% (IC50) using Cheng–Prusoff correction, KI = IC50/(1 + L*/KD), where L* is 3H-mazindol concentration used, and KD was set to mean value from control saturation assays (1.20 nM). Units are μL/min/mg of protein for these in vitro studies. Final 2 rows are neuronal uptake rates that are measures of Vmax/Km from isolated rat heart studies and not C6-hNET in vitro studies. Units are mL/min/g of wet weight for these studies.